-
Cancer vaccine strategy blocks death of tumour-specific cytotoxic T cells
europeanpharmaceuticalreview
May 03, 2018
New research could serve as the stepping-stone in constructing vaccines with a greater likelihood of finding and attacking…
-
BMS pulls the plug on Phase 3 trials of IDO1 inhibitor
pharmafile
May 03, 2018
Bristol-Myers Squibb has terminated two pivotal Phase 3 trials of BMS-986205, an IDO1 inhibitor acquired through its $800 million acquisition ...
-
MS drug could reduce painful side effects of common cancer treatment
europeanpharmaceuticalreview
May 02, 2018
Researchers have discovered why many multiple myeloma patients experience severe pain when treated with the anticancer drug bortezomib…
-
FM, Roche, DIAN collaborate for Personalized Cancer Care in China
biospectrumasia
April 28, 2018
DIAN is one of the leading independent medical laboratories in China and is dedicated to innovation in diagnostic testing platforms.
-
UK media coverage vastly underrepresents older cancer patients and their risk, study finds
pharmafile
April 27, 2018
A Cancer Research UK-funded study undertaken by the University of Glasgow has revealed that representation and coverage of cancer patients more frequently focus on younger people, notably omitting and underrepresenting older patients.
-
Improved method of delivering anti-cancer drugs
europeanpharmaceuticalreview
April 24, 2018
A new non-toxic method for delivering anti-cancer drugs to specific parts of the human body could mean the end of the severe side effects…
-
Oncology Drug Market: A Spotlight on the Dynamics
biospectrumasia
March 26, 2018
Cancer is one the most dreaded diseases worldwide and is spreading like a pandemic in Asia- Pacific region.
-
Acoustic Cluster Therapy drives drug therapies to cancer cells
europeanpharmaceuticalreview
March 22, 2018
Researchers are testing the use of pulsed sound waves to direct and focus cancer drug therapies…
-
Agilent creates new colour to detect cancer
biospectrumasia
March 19, 2018
The excellent staining characteristics of the new chromogen make it particularly useful for assessment of skin and lung tissue
-
Slow-release hydrogel aids immunotherapy for cancer
europeanpharmaceuticalreview
March 13, 2018
An immunotherapy drug embedded in a slow-release hydrogel appears to be highly effective at killing cancer cells…